Valeant Names Perrigo's Papa as CEO to Lead Turnaround

  • Drugmaker has been searching for a new CEO since March
  • Papa joined Perrigo in 2006, fended off hostile bid from Mylan

Perrigo's Papa Leaves to Lead Valeant as New CEO

Valeant Pharmaceuticals International Inc. hired Perrigo Co. CEO Joseph Papa as its new chief executive officer and chairman, tasking him with turning around an embattled drugmaker that has faced multiple setbacks over the past months.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.